Kimberly Gentile

Chief Tech/Sci/R&D Officer presso BIOHAVEN LTD.

Patrimonio netto: 5 M $ in data 31/03/2024

56 anni

Health Technology

Commercial Services

Consumer Services

Posizioni attive di Kimberly Gentile

Società	Posizione	Inizio	Fine
BIOHAVEN LTD.	Chief Tech/Sci/R&D Officer	-	-
Portage Pharmaceutical Ltd. Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The private company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux.	Chief Operating Officer	-	-

Società	Posizione	Inizio	Fine
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.	Director/Board Member	-	03/10/2022
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.	Corporate Officer/Principal	01/02/2014	03/10/2022
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01/01/2000	01/02/2014
SCIREX Corp.	Corporate Officer/Principal	01/01/1996	01/06/2000

Salem State University

Undergraduate Degree

Distribuzione geografica

Posizioni

Corporate Officer/Principal	3
Director/Board Member	1
Undergraduate Degree	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
BIOHAVEN LTD.	Health Technology

Aziende private	3
SCIREX Corp.	Commercial Services
Biohaven Pharmaceutical Holding Co. Ltd. Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.	Health Technology
Portage Pharmaceutical Ltd. Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The private company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux.	Commercial Services